Suppr超能文献

一项为期 12 周的纤维肌痛多组分治疗可改善健康状况,但对同时存在的中度抑郁无效,这是一项探索性试点研究。

A 12-week multicomponent therapy in fibromyalgia improves health but not in concomitant moderate depression, an exploratory pilot study.

机构信息

Healthcare Department, University College VIVES, Bruges, Belgium.

Rehabilitation Centre, General Hospital AZ Alma, Sijsele-Eeklo, Belgium.

出版信息

Disabil Rehabil. 2020 Jun;42(13):1886-1893. doi: 10.1080/09638288.2018.1543361. Epub 2019 Jan 29.

Abstract

Literature suggests that graded and multicomponent therapy improves outcomes in fibromyalgia, but there is no conclusive evidence in which combination to be used. This study focused on the effect of a multicomponent therapy in fibromyalgia when a combination of exercise therapy and cognitive behavioural therapy was applied. Additionally, predictors for dropping out were explored as research reports high dropout rates. Participants received graded multicomponent therapy for 12 weeks, twice a week during two hours every session by an occupational therapist, a physiotherapist, and a psychologist. Following outcome measures were assessed at baseline, weeks 6 and 12: Fibromyalgia Impact Questionnaire, Tampa scale for kinesiophobia, the Beck Depression Index, the Pain Coping Inventory (PCI), pain at the tenderpoints, grip strength, the 6-min walking test (6MWT), and cycling test. In total, 64 fibromyalgia patients were screened and included. The dropout rate was 28%. A per-protocol analysis revealed significant improvement at week 6 for the Beck Depression Index, pain at the tenderpoints and the 6MWT. At week 12, the Fibromyalgia Impact Questionnaire (FIQ), Beck Depression Index (BDI), Pain PCI, pain at the tenderpoints, grip strength, and 6MWT improved significantly. The dropout analysis showed an association in participants with a moderate BDI score at baseline. A 12-week multicomponent therapy for fibromyalgia, well described and gradually applied, showed improvement in health-related outcome. According to our results, we recommend to exclude patients with a moderate-to-severe depression at onset before starting a multicomponent therapy protocol.Implications for rehabilitationMulticomponent therapy for fibromyalgia is beneficial on different health outcomes.Moderate depression at onset should be exclusion criteria for starting with multicomponent therapy in patients with fibromyalgia.This multicomponent therapy protocol is ready to be implemented at daily practice.

摘要

文献表明,分级和多组分治疗可改善纤维肌痛的预后,但哪种组合更为有效尚无定论。本研究聚焦于纤维肌痛的多组分治疗效果,研究中应用了运动疗法和认知行为疗法的组合。此外,由于研究报告显示高脱落率,本研究还探讨了脱落的预测因素。参与者接受了 12 周的分级多组分治疗,每周两次,每次两小时,由一名职业治疗师、一名物理治疗师和一名心理学家共同提供治疗。在基线、第 6 周和第 12 周评估以下结果测量指标:纤维肌痛影响问卷、坦帕运动恐惧量表、贝克抑郁指数、疼痛应对量表、触痛点疼痛、握力、6 分钟步行测试(6MWT)和骑行测试。总共筛选了 64 名纤维肌痛患者并纳入研究。脱落率为 28%。意向性治疗分析显示,贝克抑郁指数、触痛点疼痛和 6MWT 在第 6 周时显著改善。在第 12 周时,纤维肌痛影响问卷(FIQ)、贝克抑郁指数(BDI)、疼痛应对量表(PCI)、触痛点疼痛、握力和 6MWT 均显著改善。脱落分析显示,基线时 BDI 评分中度的参与者存在关联。为期 12 周的纤维肌痛多组分治疗方案描述详尽,且逐渐实施,可改善与健康相关的预后。根据我们的结果,我们建议在开始多组分治疗方案前,排除发病时存在中重度抑郁的患者。康复意义纤维肌痛的多组分治疗对不同的健康结果均有益。发病时存在中度抑郁应作为纤维肌痛患者开始多组分治疗的排除标准。该多组分治疗方案已准备好在日常实践中实施。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验